The FDA has approved the second biosimilar to Humira Cyltezo for several gastroenterological rheumatological and dermatological indications.Cyltezo adalimumabadbm Boehringer Ingelheim a biosimilar to Humira adalimumab AbbVie is an antiTNF drug delivered by...
↧